Uncategorized - April 29, 2026
Tortugas Neuroscience launches with USD 106 million for mid‑stage brain drugs
The US‑based company has debuted in combined seed and Series A financing to advance a portfolio of mid‑stage neurology and neuropsychiatry drugs in‑licensed from Eisai and Hansoh.
Biotech Business - December 9, 2025
Leqembi included in China’s commercial insurance innovative drug list
BioArctic’s partner Eisai has announced that Leqembi (lecanemab), has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.
Collaboration - July 30, 2025
The new European Life Science Strategy has been launched
Earlier this summer, the European Commission launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.
Biotech Business - December 9, 2024
MetaCurUm secures SEK 1 million grant
MetaCurUm has been awarded SEK 1 million from the Swedish Innovation Agency, Vinnova, under the "Acceleration of Deeptech Companies 2024" initiative.
Uncategorized - December 1, 2024
Mentice appoints new CEO
Mentice has appointed Frans Venker as its new Chief Executive Officer, effective January 1, 2025.
Collaboration - September 14, 2024
Are you ready for Nordic Life Science Days 2024?
The 11th edition of NLSDays is being held in Malmö on September 18-19. Program Director, Marjo Puumalainen, gives us an inside look into the upcoming conference.
